Drug intelligence / Profile preview

Xiaolan Box Probiotics

Development stage: Unknown
Lead developer: Central South University
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Xiaolan Box Probiotics is a multi-strain probiotic supplement developed through a research collaboration with the Xiangya School of Public Health at Central South University. Primarily indicated for the management of functional constipation and the restoration of intestinal microbiota balance, the product is formulated as a solid drink powder. It typically contains a proprietary blend of probiotic strains, such as *Bifidobacterium animalis* subsp. *lactis* and *Lactobacillus acidophilus*, often supplemented with prebiotics like inulin and fructooligosaccharides to enhance bacterial colonization. The mechanism of action involves modulating the gut microbiome to stimulate intestinal peristalsis, lower luminal pH through the production of short-chain fatty acids (SCFAs), and improve stool consistency and transit time. It is marketed as a health supplement (nutraceutical) in China, leveraging the clinical research expertise of the Xiangya School of Public Health to address common gastrointestinal motility issues.

Brand names: Xiaolan Box小蓝盒
Other names: Xiaolan Box Probiotic Solid Drink小蓝盒益生菌固体饮料

Beyond the preview

Go deeper on Xiaolan Box Probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaolan Box Probiotics.

Explore the full profile